China Biologic Products Inc (CBPO):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:China Biologic Products Inc (CBPO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9831
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:65
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:中国
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
China Biologic Products Inc (China Biologic) is a biopharmaceutical company that offers plasma collection, research and development, production, commercialization of biopharmaceutical products and development of treatment products. The company manufactures, develops, and markets biologic products for the prevention and treatment of various diseases. Its plasma products include human albumin, human tetanus immunoglobulin, human rabies immunoglobulin, human immunoglobulin for intravenous injection, human hepatitis B immunoglobulin, thymopolypeptides injection, human immunoglobulin, and human coagulation factor VIII. China Biologic’s other product includes placenta polypeptide. The company provides services such as plasma collection, research and development, production, and commercialization of biopharmaceutical products. It offers products to hospitals and other healthcare facilities in China. China Biologic is headquartered in Beijing, China.

China Biologic Products Inc (CBPO) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
China Biologic Products Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
China Biologic Products Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
China Biologic Products Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
China Biologic Products Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
China Biologic Products Inc, Medical Devices Deals, 2012 to YTD 2018 9
China Biologic Products Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
China Biologic Products Inc, Pharmaceuticals & Healthcare, Deal Details 11
Private Equity 11
China Biologic Products to Raise USD590 Million in Private Placement of Shares 11
Consortium of Investors to Acquire Remaining Shares in China Biologic Products for USD3.9 Billion 13
CCRE Holdings to Acquire Remaining 94.9% Stake in China Biologic Products 15
Equity Offering 16
China Biologic Products Raises Funds through Public Offering of Shares 16
China Biologic Prices Public Offering of Shares for USD73.5 Million 18
China Biologic Prices Public Offering of Shares for USD30 Million 19
Acquisition 21
China Biologic Products Acquires Remaining 15.3% Stake in Guizhou Taibang Biological Products for USD62.5 Million 21
China Biologic Products Inc – Key Competitors 22
China Biologic Products Inc – Key Employees 23
China Biologic Products Inc – Locations And Subsidiaries 24
Head Office 24
Other Locations & Subsidiaries 24
Recent Developments 25
Financial Announcements 25
Nov 01, 2018: China Biologic reports financial results for the third quarter of 2018 25
Aug 03, 2018: China Biologic reports financial results for the second quarter of 2018 31
May 04, 2018: China Biologic Reports Financial Results For First Quarter Of 2018 37
May 04, 2018: China Biologic Announces First Quarter 2018 Financial Results 40
Feb 28, 2018: China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2017 43
Nov 01, 2017: China Biologic Reports Unaudited Financial Results for the Third Quarter of 2017 47
Aug 02, 2017: China Biologic Reports Financial Results for the Second Quarter of 2017 51
May 03, 2017: China Biologic Reports Financial Results for the First Quarter of 2017 55
Feb 23, 2017: China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2016 58
Corporate Communications 62
Aug 13, 2018: China Biologic names Bing Li as new CEO 62
Legal and Regulatory 63
Aug 28, 2018: China Biologic responds to lawsuit filed in Cayman Islands by former Chairman 63
Other Significant Developments 64
Jan 08, 2018: China Biologic Announces Corporate Update 64
Appendix 65
Methodology 65
About GlobalData 65
Contact Us 65
Disclaimer 65

List of Tables
China Biologic Products Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
China Biologic Products Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
China Biologic Products Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
China Biologic Products Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
China Biologic Products Inc, Deals By Therapy Area, 2012 to YTD 2018 8
China Biologic Products Inc, Medical Devices Deals, 2012 to YTD 2018 9
China Biologic Products Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
China Biologic Products to Raise USD590 Million in Private Placement of Shares 11
Consortium of Investors to Acquire Remaining Shares in China Biologic Products for USD3.9 Billion 13
CCRE Holdings to Acquire Remaining 94.9% Stake in China Biologic Products 15
China Biologic Products Raises Funds through Public Offering of Shares 16
China Biologic Prices Public Offering of Shares for USD73.5 Million 18
China Biologic Prices Public Offering of Shares for USD30 Million 19
China Biologic Products Acquires Remaining 15.3% Stake in Guizhou Taibang Biological Products for USD62.5 Million 21
China Biologic Products Inc, Key Competitors 22
China Biologic Products Inc, Key Employees 23
China Biologic Products Inc, Subsidiaries 24

List of Figures
China Biologic Products Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
China Biologic Products Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
China Biologic Products Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
China Biologic Products Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
China Biologic Products Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
China Biologic Products Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
China Biologic Products Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
China Biologic Products Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
China Biologic Products Inc, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[China Biologic Products Inc (CBPO):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Movenpick Schweiz AG:企業の戦略・SWOT・財務情報
    Movenpick Schweiz AG - Strategy, SWOT and Corporate Finance Report Summary Movenpick Schweiz AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • RPC Astrapak:企業の財務・戦略的SWOT分析
    RPC Astrapak - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pote …
  • Avedro Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Avedro Inc (Averdro) is a medical device company that manufactures and distributes cross-linking systems and riboflavin ophthalmic products. The company’s products include mosaic systems for PiXL, lasik xtra, and accelerated cross-linking; KXL systems for lasik xtra and accelerated cross-lin …
  • Tribune Media Company:戦略・SWOT・企業財務分析
    Tribune Media Company - Strategy, SWOT and Corporate Finance Report Summary Tribune Media Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Energisa SA (ENGI11):電力:M&Aディール及び事業提携情報
    Summary Energisa SA (Energisa) is a power utility that generates, distributes and sells electricity. The company generates electricity through wind, small hydropower, and biomass resources. It also operates and maintains hydroelectric power plants for other companies; constructs and refurbishes gene …
  • BASF SE:企業の戦略・SWOT・財務情報
    BASF SE - Strategy, SWOT and Corporate Finance Report Summary BASF SE - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, pr …
  • Bureau Veritas SA (BVI)-エネルギー分野:企業M&A・提携分析
    Summary Bureau Veritas SA (Bureau Veritas) is a testing, inspection and certification service provider that offers varied services such as asset management, certification, classification, consulting, inspection and audits, testing and analysis, and training. The company serves aeronautics, agricultu …
  • The J.M. Smucker Co:企業の戦略・SWOT・財務情報
    The J.M. Smucker Co - Strategy, SWOT and Corporate Finance Report Summary The J.M. Smucker Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Tullow Oil plc:企業の戦略・SWOT・財務情報
    Tullow Oil plc - Strategy, SWOT and Corporate Finance Report Summary Tullow Oil plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Intra Energy Corporation Ltd (IEC):企業の財務・戦略的SWOT分析
    Intra Energy Corporation Ltd (IEC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Shell Canada Ltd-石油・ガス分野:企業M&A・提携分析
    Summary Shell Canada Ltd (Shell Canada), a subsidiary of Royal Dutch Shell plc is an integrated oil and gas company that offers upstream and downstream services. The company's upstream services include markets and trades natural gas and power and exploration and extraction of natural gas. Its downst …
  • PricewaterhouseCoopers LLP:企業の戦略的SWOT分析
    PricewaterhouseCoopers LLP - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • China Vanke Co., Ltd.:企業の戦略・SWOT・財務情報
    China Vanke Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary China Vanke Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Medifast, Inc. (MED):企業の財務・戦略的SWOT分析
    Medifast, Inc. (MED) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Defense Commissary Agency:企業の戦略的SWOT分析
    Defense Commissary Agency - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Seagate Technology Public Limited Company:企業の戦略・SWOT・財務情報
    Seagate Technology Public Limited Company - Strategy, SWOT and Corporate Finance Report Summary Seagate Technology Public Limited Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SW …
  • Genera Biosystems Ltd (GBI):医療機器:M&Aディール及び事業提携情報
    Summary Genera Biosystems Ltd (GBL) is a multiplexed molecular diagnostic testing product developer. The company offers RTIplex and PapType molecular diagnostic test. Its RTIplex is a multiplexed and automated PCR based test for detection of viral and bacterial respiratory pathogens; and PapType is …
  • Sygnity SA (SGN):企業の財務・戦略的SWOT分析
    Sygnity SA (SGN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Kindred Healthcare Inc (KND)-製薬・医療分野:企業M&A・提携分析
    Summary Kindred Healthcare Inc (Kindred Healthcare) is a healthcare services provider with focus on post-acute care services. The company through its subsidiaries offers home health, hospice and community care services to patients in homes, nursing centers, and other residential settings. It operate …
  • Aushon BioSystems Inc-医療機器分野:企業M&A・提携分析
    Summary Aushon BioSystems Inc (Aushon) is a medical device provider that offers biomarker measurement and analysis products. The company provides biomarker therapeutic areas in microarray printing technology. Its products include ciraplex assay, cirascan imaging and cirasoft analysis and cira servic …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆